메뉴 건너뛰기




Volumn 2, Issue 1, 2007, Pages 34-39

Hepatocellular carcinoma. Therapeutic perspectives;Hepatozelluläres karzinom. Therapeutische perspektiven

Author keywords

Antiangiogenesis; Gene therapy; Hepatocellular carcinoma; Immune therapy; Targeted therapy

Indexed keywords


EID: 33846376437     PISSN: 18619681     EISSN: 1861969X     Source Type: Journal    
DOI: 10.1007/s11377-006-0052-7     Document Type: Review
Times cited : (2)

References (26)
  • 1
    • 0344188096 scopus 로고    scopus 로고
    • An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
    • Bischoff J R, Kirn DH, Williams A et al. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376
    • (1996) Science , vol.274 , pp. 373-376
    • Bischoff, J.R.1    Kirn, D.H.2    Williams, A.3
  • 2
    • 0042268107 scopus 로고    scopus 로고
    • Oncolytic viruses for genetic therapy of gastrointestinal tumors
    • Bitzer M, Lauer UM (2003) Oncolytic viruses for genetic therapy of gastrointestinal tumors. Z Gastroenterol 7: 667-674
    • (2003) Z Gastroenterol , vol.7 , pp. 667-674
    • Bitzer, M.1    Lauer, U.M.2
  • 3
    • 0035871639 scopus 로고    scopus 로고
    • T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein
    • Butterfield LH, Meng WS, Koh A et al. (2001) T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. J Immunol 166: 5300-5308
    • (2001) J Immunol , vol.166 , pp. 5300-5308
    • Butterfield, L.H.1    Meng, W.S.2    Koh, A.3
  • 4
    • 7044226216 scopus 로고    scopus 로고
    • Immunotherapeutic strategies for hepatocellular carcinoma
    • Butterfield LH (2004) Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127: S232-S241
    • (2004) Gastroenterology , vol.127
    • Butterfield, L.H.1
  • 5
    • 29144474459 scopus 로고    scopus 로고
    • Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma
    • Eckel F, von Delius S, Mayr M et al. (2005) Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology 69: 363-371
    • (2005) Oncology , vol.69 , pp. 363-371
    • Eckel, F.1    von Delius, S.2    Mayr, M.3
  • 6
    • 0034797669 scopus 로고    scopus 로고
    • Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice
    • Geissler M, Mohr L, Köhler G et al. (2001) Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice. Gastroenterology 121: 931-939
    • (2001) Gastroenterology , vol.121 , pp. 931-939
    • Geissler, M.1    Mohr, L.2    Köhler, G.3
  • 7
    • 0033769892 scopus 로고    scopus 로고
    • Mouse alpha-fetoprotein- specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice
    • Grimm CF, Ortmann D, Mohr L et al. (2000) Mouse alpha-fetoprotein- specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 119: 1104-1112
    • (2000) Gastroenterology , vol.119 , pp. 1104-1112
    • Grimm, C.F.1    Ortmann, D.2    Mohr, L.3
  • 8
    • 85047699490 scopus 로고    scopus 로고
    • Habib N, Salama H, Abd El Latif Abu Median A et al. (2002) Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther 9: 254-259
    • Habib N, Salama H, Abd El Latif Abu Median A et al. (2002) Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther 9: 254-259
  • 9
    • 9644255742 scopus 로고    scopus 로고
    • Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
    • Hopfner M, Sutter AP, Huether A et al. (2004) Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J Hepatol 41: 1008-1016
    • (2004) J Hepatol , vol.41 , pp. 1008-1016
    • Hopfner, M.1    Sutter, A.P.2    Huether, A.3
  • 10
    • 0037384518 scopus 로고    scopus 로고
    • A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
    • Iwashita Y, Tahara K, Goto S et al. (2003) A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother, 52: 155-161 2003
    • (2003) Cancer Immunol Immunother , vol.52 , pp. 155-161
    • Iwashita, Y.1    Tahara, K.2    Goto, S.3
  • 11
    • 0034868947 scopus 로고    scopus 로고
    • Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro
    • Krohne TU, Shankara S, Geissler M et al. (2001) Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. Hepatology 34: 511-518
    • (2001) Hepatology , vol.34 , pp. 511-518
    • Krohne, T.U.1    Shankara, S.2    Geissler, M.3
  • 12
    • 12144286051 scopus 로고    scopus 로고
    • Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma
    • Kuang M, Peng BG, Lu MD et al. (2004) Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res 10: 1574-1579
    • (2004) Clin Cancer Res , vol.10 , pp. 1574-1579
    • Kuang, M.1    Peng, B.G.2    Lu, M.D.3
  • 13
    • 0037295403 scopus 로고    scopus 로고
    • ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
    • Liu BL, Robinson M, Han ZQ et al. (2003) ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther 10: 292-303
    • (2003) Gene Ther , vol.10 , pp. 292-303
    • Liu, B.L.1    Robinson, M.2    Han, Z.Q.3
  • 15
    • 0034212631 scopus 로고    scopus 로고
    • Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus
    • Pawlik TM, Nakamura, H, Yoon SS et al. (2000) Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res 60: 2790-2795
    • (2000) Cancer Res , vol.60 , pp. 2790-2795
    • Pawlik, T.M.1    Nakamura, H.2    Yoon, S.S.3
  • 16
    • 27244447373 scopus 로고    scopus 로고
    • Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
    • Philip PA, Mahoney MR, Allmer C et al. (2005) Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol 23: 6657-6663
    • (2005) J Clin Oncol , vol.23 , pp. 6657-6663
    • Philip, P.A.1    Mahoney, M.R.2    Allmer, C.3
  • 17
    • 2342570309 scopus 로고    scopus 로고
    • Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
    • Sangro B, Mazzolini G, Ruiz J et al. (2004) Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol 22: 1389-1397
    • (2004) J Clin Oncol , vol.22 , pp. 1389-1397
    • Sangro, B.1    Mazzolini, G.2    Ruiz, J.3
  • 20
    • 20044382799 scopus 로고    scopus 로고
    • Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
    • Strumberg D, Richly H, Hilger RA et al. (2005) Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol 23: 965-972
    • (2005) J Clin Oncol , vol.23 , pp. 965-972
    • Strumberg, D.1    Richly, H.2    Hilger, R.A.3
  • 21
    • 0034596475 scopus 로고    scopus 로고
    • Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
    • Takayama T, Sekine T, Makuuchi M et al. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807
    • (2000) Lancet , vol.356 , pp. 802-807
    • Takayama, T.1    Sekine, T.2    Makuuchi, M.3
  • 22
    • 32944480899 scopus 로고    scopus 로고
    • Opportunities for targeted therapies in hepatocellular carcinoma
    • Thomas MB, Abbruzzese JL (2005) Opportunities for targeted therapies in hepatocellular carcinoma. J Clin Oncol 23: 8093-8108
    • (2005) J Clin Oncol , vol.23 , pp. 8093-8108
    • Thomas, M.B.1    Abbruzzese, J.L.2
  • 23
    • 0031890627 scopus 로고    scopus 로고
    • Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
    • Wada Y, Nakashima O, Kutami R et al. (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27: 407-414
    • (1998) Hepatology , vol.27 , pp. 407-414
    • Wada, Y.1    Nakashima, O.2    Kutami, R.3
  • 24
    • 0035177693 scopus 로고    scopus 로고
    • Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene
    • Wybranietz WA, Gross CD Phelan A et al. (2001) Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene. Gene Ther 8: 1654-1664
    • (2001) Gene Ther , vol.8 , pp. 1654-1664
    • Wybranietz, W.A.1    Gross, C.D.2    Phelan, A.3
  • 25
    • 0001642806 scopus 로고    scopus 로고
    • Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene
    • Xu G. W, Sun ZT, Forrester K et al. (1996) Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene. Hepatology 24: 1264-1268
    • (1996) Hepatology , vol.24 , pp. 1264-1268
    • Xu, G.W.1    Sun, Z.T.2    Forrester, K.3
  • 26
    • 0036320613 scopus 로고    scopus 로고
    • Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors
    • Zender L, Kock R, Eckhard M et al. (2002) Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors. Gastroenterology 123: 608-618
    • (2002) Gastroenterology , vol.123 , pp. 608-618
    • Zender, L.1    Kock, R.2    Eckhard, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.